Publications

BioMed Realty to double U.K. life sciences portfolio
Real Estate - SEPTEMBER 21, 2021

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

BioMed Realty to double U.K. life sciences portfolio

by Andrea Zander

BioMed Realty has plans to deliver approximately 800,000 square feet of additional high-quality purpose-built lab space, following the acquisition of two new sites in Cambridge, England.

BioMed, a leading provider of real estate solutions to the life science and technology industries, has acquired Cambridge International Technology Park, a 15-acre site on Fulbourn Road, from Abstract, and a 27-acre land plot at Granta Park from The Welding Institute. The proposed two new sites are still subject to planning consent.

The acquisitions would double BioMed’s current life sciences real estate in Cambridge and support the creation of up to 2,700 new jobs.

The United Kingdom’s life sciences sector is a crucial part of the British economy, supporting 250,000 jobs and contributing more than £80 billion (€93 billion/$109 billion) to GDP each year. As the largest life sciences market in the United Kingdom, Cambridge — the birthplace of stem cell research and artifi

Forgot your username or password?